|
RAB27A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.984640E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.00039999995083E-06 |
| Normal-vs-Stage2 |
2.888100E-02 |
| Normal-vs-Stage3 |
4.957000E-03 |
| Normal-vs-Stage4 |
4.317600E-02 |
| Stage1-vs-Stage2 |
2.871200E-01 |
| Stage1-vs-Stage3 |
2.087400E-01 |
| Stage1-vs-Stage4 |
6.724600E-01 |
| Stage2-vs-Stage3 |
9.801200E-01 |
| Stage2-vs-Stage4 |
7.746000E-01 |
| Stage3-vs-Stage4 |
7.064000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.22209999999934E-05 |
| Normal-vs-AfricanAmerican |
1.683630E-03 |
| Normal-vs-Asian |
2.588400E-01 |
| Caucasian-vs-AfricanAmerican |
6.130100E-02 |
| Caucasian-vs-Asian |
2.712600E-01 |
| AfricanAmerican-vs-Asian |
7.152800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.8885000000044E-05 |
| Normal-vs-Female |
2.068100E-02 |
| Male-vs-Female |
8.953700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.72660000000403E-05 |
| Normal-vs-Extreme_Weight |
2.24919999999296E-05 |
| Normal-vs-Obese |
3.799100E-03 |
| Normal-vs-Extreme_Obese |
3.90100000000615E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.370200E-01 |
| Normal_Weight-vs-Obese |
2.234400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.894200E-01 |
| Extreme_Weight-vs-Obese |
2.756500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.581000E-01 |
| Obese-vs-Extreme_Obese |
2.469900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.692600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.443500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.73849999999654E-05 |
| Normal-vs-Age(81-100Yrs) |
1.2011000000145E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.580500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.542100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.702900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.193700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.324920E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.055800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.54605999999058E-05 |
| Normal-VS-Type2 PRCC |
1.249850E-04 |
| Normal-VS-KIRP CIMP |
2.123000E-01 |
| Normal-VS-Unclassified PRCC |
3.465800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.582400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.213100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.294390E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.78500000000059E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.193800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.156700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.23580000000046E-05 |
| Normal-vs-N1 |
7.046400E-02 |
| Normal-vs-N2 |
1.851760E-01 |
| N0-vs-N1 |
2.416000E-02 |
| N0-vs-N2 |
6.533600E-01 |
| N1-vs-N2 |
5.624000E-01 |
|
|
